EUVIMEDEUVIMED entdecken
Open Access

Elucidating the cellular determinants of targeted membrane protein degradation by lysosome-targeting chimeras

Green Ahn iD, Nicholas M Riley iD, Roarke A Kamber iD, Simon Wisnovsky, Salvador Moncayo von Hase iD, Michael C Bassik iD, Steven M Banik iD, Carolyn R Bertozzi iD

Science · 20.10.2023 · 382 (6668)

DOI: 10.1126/science.adf6249 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science, erschienen am 20.10.2023. Verfasst von Green Ahn und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Stanford University, Stanford, CA 94305, USA. Hauptthemen laut MEDLINE: Lysosomes, Membrane Proteins, Proteolysis, Receptor, IGF Type 2. Die Arbeit wurde bisher 204-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Targeted protein degradation can provide advantages over inhibition approaches in the development of therapeutic strategies. Lysosome-targeting chimeras (LYTACs) harness receptors, such as the cation-independent mannose 6–phosphate receptor (CI-M6PR), to direct extracellular proteins to lysosomes. In this work, we used a genome-wide CRISPR knockout approach to identify modulators of LYTAC-mediated membrane protein degradation in human cells. We found that disrupting retromer genes improved target degradation by reducing LYTAC recycling to the plasma membrane. Neddylated cullin-3 facilitated LYTAC-complex lysosomal maturation and was a predictive marker for LYTAC efficacy. A substantial fraction of cell surface CI-M6PR remains occupied by endogenous M6P-modified glycoproteins. Thus, inhibition of M6P biosynthesis increased the internalization of LYTAC-target complexes. Our findings inform design strategies for next-generation LYTACs and elucidate aspects of cell surface receptor occupancy and trafficking.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LysosomesMembrane ProteinsProteolysisReceptor, IGF Type 2Proteolysis Targeting ChimeraHumansHeLa CellsCullin Proteins

Substanzen

Membrane ProteinsReceptor, IGF Type 2CUL3 protein, humanCullin ProteinsProteolysis Targeting Chimeracation-dependent mannose-6-phosphate receptor

Autor:innen und Institutionen

  • Department of Chemistry, Stanford University, Stanford, CA 94305, USA.
  • Sarafan ChEM-H, Stanford University, Stanford, CA 94305, USA.
  • Department of Genetics, Stanford University, Stanford, CA 94305, USA.
  • Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada.
  • Howard Hughes Medical Institute, Stanford University, Stanford, CA 94305, USA.

ORCID-Profile: Green Ahn, Nicholas M Riley, Roarke A Kamber, Salvador Moncayo von Hase, Michael C Bassik, Steven M Banik, Carolyn R Bertozzi

Förderung

  • NIGMS NIH HHS
  • NCI NIH HHS

Zitieren

APA

Ahn, G., Riley, N. M., Kamber, R. A., Wisnovsky, S., Moncayo von Hase, S., Bassik, M. C., Banik, S. M., & Bertozzi, C. R. (2023). Elucidating the cellular determinants of targeted membrane protein degradation by lysosome-targeting chimeras. Science, 382(6668). https://doi.org/10.1126/science.adf6249

Vancouver

Ahn G, Riley NM, Kamber RA, Wisnovsky S, Moncayo von Hase S, Bassik MC, et al. Elucidating the cellular determinants of targeted membrane protein degradation by lysosome-targeting chimeras. Science. 2023;382(6668). doi:10.1126/science.adf6249

BibTeX
@article{Ahn2023,
  author = {Ahn, Green and Riley, Nicholas M and Kamber, Roarke A and Wisnovsky, Simon and Moncayo von Hase, Salvador and Bassik, Michael C and Banik, Steven M and Bertozzi, Carolyn R},
  title = {Elucidating the cellular determinants of targeted membrane protein degradation by lysosome-targeting chimeras},
  journal = {Science},
  year = {2023},
  volume = {382},
  number = {6668},
  doi = {10.1126/science.adf6249}
}
Kostenlos starten →